Squarepoint
VTVT icon

Squarepoint’s vTv Therapeutics VTVT Stock Holding History

Squarepoint’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-720
Closed -$66K – 3475
2021
Q2 		$66K Buy
+720
New +$72.9K ﹤0.01% 3077
2021
Q1 		– Sell
-821
Closed -$61K – 3668
2020
Q4 		$61K Sell
821
-2
-0.2% -$153 ﹤0.01% 2784
2020
Q3 		$58K Sell
823
-668
-45% -$58.7K ﹤0.01% 2355
2020
Q2 		$134K Buy
+1,491
New +$147K ﹤0.01% 1946

Other funds holding VTVT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WAG
Winthrop Advisory Group Boston, Massachusetts $1.48B AUM 22.62% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $29.1B AUM 22.79% 1-Year Est. Return

Squarepoint's VTVT Position: Q3 2021 in Review

Squarepoint sold out of vTv Therapeutics (VTVT) in Q3 2021, closing a stake of 720 shares — an estimated $66K sold.

Squarepoint first reported a position in VTVT in Q2 2020 and held it in 4 quarters. The position peaked at $134K in Q2 2020. 31 funds tracked by Wall St. Rank hold VTVT as of Q3 2021.

  • Squarepoint reported no remaining vTv Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Squarepoint sold 720 vTv Therapeutics shares in Q3 2021, an estimated $66K.
  • Squarepoint first reported a position in vTv Therapeutics in Q2 2020 and held it in 4 quarters.
  • Squarepoint's vTv Therapeutics position peaked at $134K in Q2 2020.
  • 31 funds tracked by Wall St. Rank held vTv Therapeutics as of Q3 2021.

Based on Squarepoint's 13F filing for Q3 2021, filed 15 Nov 2021.